Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 10 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

10 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Oct. 4, 2023 ZNTL S 10b5-1 8,906 $19.43 $173,044 107,407 Direct -7.66% Disposed -85.7% (price as of 2026-10-05)
Oct. 4, 2023 ZNTL S 10b5-1 1,722 $19.91 $34,285 105,685 Direct -1.60% Disposed -86.0% (price as of 2026-10-05)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
July 14, 2025 STTK Stock Option (Right to Buy) Common Stock (33,150) $0.82 July 14, 2035 33,150 Acquired
June 21, 2024 STTK Stock Option (Right to Buy) Common Stock (27,700) $4.37 June 21, 2034 27,700 Acquired
May 26, 2023 STTK Stock Option (Right to Buy) Common Stock (40,258) $2.72 May 26, 2033 40,258 Acquired
Feb. 1, 2023 ZNTL Stock Option (Right to Buy) Common Stock (23,687) $23.65 Jan. 31, 2033 23,687 Acquired
Oct. 3, 2022 ZNTL Stock Option (Right to Buy) Common Stock (300,000) $22.21 Oct. 2, 2032 300,000 Acquired
Oct. 3, 2022 ZNTL Stock Option (Right to Buy) Common Stock (100,000) $22.21 Oct. 2, 2032 100,000 Acquired
June 8, 2022 STTK Stock Option (Right to Buy) Common Stock (40,258) $4.32 June 8, 2032 40,258 Acquired
Nov. 12, 2021 STTK Stock Option (Right to Buy) Common Stock (10,467) $19.27 Nov. 12, 2031 10,467 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

ZNTL

M.D.Chief Medical Officer (8)
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2022 $127,500 · $2,221,000 $6,248,317 $229,500 · $4,340 $8,830,657

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.